Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 1969115)

1.
2.

AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?

Zaretsky MD.

Genetica. 1995;95(1-3):91-101. Review. Erratum in: Genetica 1995;96(3):307.

PMID:
7744265
4.

Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.

Darbyshire J, Foulkes M, Peto R, Duncan W, Babiker A, Collins R, Hughes M, Peto T, Walker A.

Cochrane Database Syst Rev. 2000;(3):CD002039. Review.

PMID:
10908524
5.

NIH conference. Antiretroviral therapy in AIDS.

Broder S, Mitsuya H, Yarchoan R, Pavlakis GN.

Ann Intern Med. 1990 Oct 15;113(8):604-18. Review.

PMID:
1698042
7.

Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.

Mofenson LM, Moye J Jr.

Pediatr Res. 1993 Jan;33(1 Suppl):S80-7; discussion S87-9. Review.

PMID:
8433880
8.

Zidovudine toxicity. Clinical features and management.

Rachlis A, Fanning MM.

Drug Saf. 1993 Apr;8(4):312-20. Review.

PMID:
8481217
9.

Antiviral therapy of HIV infection.

Richman DD.

Annu Rev Med. 1991;42:69-90. Review.

PMID:
2035995
10.

Zidovudine in symptomless HIV infection.

[No authors listed]

Lancet. 1989 Feb 25;1(8635):415-6. Review. No abstract available.

PMID:
2563790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk